180 related articles for article (PubMed ID: 23059459)
1. Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy.
Hinder LM; Vincent AM; Hayes JM; McLean LL; Feldman EL
Exp Neurol; 2013 Jan; 239():102-10. PubMed ID: 23059459
[TBL] [Abstract][Full Text] [Related]
2. Chewing the fat: genetic approaches to model dyslipidemia-induced diabetic neuropathy in mice.
Guilford BL; Wright DE
Exp Neurol; 2013 Oct; 248():504-8. PubMed ID: 23933575
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
Atkinson RD; Coenen KR; Plummer MR; Gruen ML; Hasty AH
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E284-90. PubMed ID: 18029445
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459
[TBL] [Abstract][Full Text] [Related]
5. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
[TBL] [Abstract][Full Text] [Related]
6. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.
Fujii A; Allen TJ; Nestel PJ
Atherosclerosis; 2007 Jul; 193(1):55-61. PubMed ID: 16996521
[TBL] [Abstract][Full Text] [Related]
7. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding.
Kobayashi K; Forte TM; Taniguchi S; Ishida BY; Oka K; Chan L
Metabolism; 2000 Jan; 49(1):22-31. PubMed ID: 10647060
[TBL] [Abstract][Full Text] [Related]
8. Mapping and Congenic Dissection of Genetic Loci Contributing to Hyperglycemia and Dyslipidemia in Mice.
Shi W; Wang Q; Choi W; Li J
PLoS One; 2016; 11(2):e0148462. PubMed ID: 26859786
[TBL] [Abstract][Full Text] [Related]
9. Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor.
Wu KK; Wu TJ; Chin J; Mitnaul LJ; Hernandez M; Cai TQ; Ren N; Waters MG; Wright SD; Cheng K
Atherosclerosis; 2005 Aug; 181(2):251-9. PubMed ID: 16039278
[TBL] [Abstract][Full Text] [Related]
10. Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.
Hanh NT; Nhung BT; Dao DT; Tuyet LT; Hop LT; Binh TQ; Thuc VT
Lipids Health Dis; 2016 Oct; 15(1):176. PubMed ID: 27724906
[TBL] [Abstract][Full Text] [Related]
11. The APOE
Pouwer MG; Heinonen SE; Behrendt M; Andréasson AC; van Koppen A; Menke AL; Pieterman EJ; van den Hoek AM; Jukema JW; Leighton B; Jönsson-Rylander AC; Princen HMG
J Diabetes Res; 2019; 2019():9727952. PubMed ID: 30949516
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Chinese herbal medicine Guanxinkang on lipid metabolism and serum C-reactive protein, amyloid A protein and fibrinogen in apolipoprotein E-knockout mice with atherosclerosis].
Mao MJ; Hu JP; Chen FR; Zhang YY; Liu P
Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):306-12. PubMed ID: 21419084
[TBL] [Abstract][Full Text] [Related]
13. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.
Jun JY; Ma Z; Pyla R; Segar L
Atherosclerosis; 2012 Dec; 225(2):341-7. PubMed ID: 23099119
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats.
Shen L; Tso P; Wang DQ; Woods SC; Davidson WS; Sakai R; Liu M
Physiol Behav; 2009 Aug; 98(1-2):223-8. PubMed ID: 19481557
[TBL] [Abstract][Full Text] [Related]
15. Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice.
Silva AR; Aguilar EC; Alvarez-Leite JI; da Silva RF; Arantes RM; Bader M; Alenina N; Pelli G; Lenglet S; Galan K; Montecucco F; Mach F; Santos SH; Santos RA
Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(11):R1323-30. PubMed ID: 24089374
[TBL] [Abstract][Full Text] [Related]
16. Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice.
Narvekar P; Berriel Diaz M; Krones-Herzig A; Hardeland U; Strzoda D; Stöhr S; Frohme M; Herzig S
Diabetes; 2009 May; 58(5):1040-9. PubMed ID: 19188430
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerotic dyslipidemia revealed by plasma lipidomics on ApoE
Chen Y; Wen S; Jiang M; Zhu Y; Ding L; Shi H; Dong P; Yang J; Yang Y
Atherosclerosis; 2017 Jul; 262():78-86. PubMed ID: 28527370
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.
Bonthu S; Heistad DD; Chappell DA; Lamping KG; Faraci FM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2333-40. PubMed ID: 9409199
[TBL] [Abstract][Full Text] [Related]
20. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
